2023 ON DEMAND: QM Series 12 - Part 1 Bundle
- Registration Closed
The 2023-2024 QM Series 12 theme is Embrace Change: Growing Your Cellular Therapy Services. Each webinar will equip your organization with practical strategies and insights to incorporate a new service or product into your cellular therapy organization while ensuring compliance, optimizing patient outcomes, and driving continuous improvement. Each webinar includes a 45-minute live lecture and a 15-minute Q&A session.
This bundle series includes all the ON-DEMAND webinars from the 2023 QM Series 12 - Part 1:
- Facility Needs Assessment/Change Control
- Establishing Quality Indicators
- Written Agreements
- Program's Perspective: Three Views
To purchase QM Series 12 - Part 2 LIVE Bundle: Purchase
Advanced Search This List
-
The 2023 QM Series 12 theme is Embrace Change: Growing Your Cellular Therapy Services. Each webinar will equip your organization with practical strategies and insights to incorporate a new service or product into your cellular therapy organization while ensuring compliance, optimizing patient outcomes, and driving continuous improvement. Each webinar will include a 45-minute live lecture and a 15-minute Q&A session. Ed Brindle, MSc, MLT is the Quality Manager for the Hamilton Health Sciences, Cellular Therapy and Transplantation Program.
After this webinar, attendees should be able to:
-
Determine a timeline, regulatory requirements, and potential metrics to assess needs.
-
Evaluate potential benefits and value added by performing a needs assessment.
-
Identify gaps through change control and how they affect other processes within the program.
-
Assess staffing, training, and product needs for the successful implementation of a new service.
Purchase the QM Series 12 - Part 1 On-Demand Bundle: PURCHASE
Ed Brindle
QA Manager - CTT Program
Hamilton Health Sciences
Ed's extensive educational background and professional certifications testify to his qualifications. He holds a Bachelor’s in Biological Sciences from Glasgow Caledonian University, a master’s in biomedical sciences at Napier University in Edinburgh, UK, and a Certificate in Quality Management with distinction at the University of Manitoba. Ed's unwavering dedication to quality management is evident in his over 30 years of experience as a Medical Lab Technologist in Hematology, Transfusion, Microbiology, Clinical Biochemistry, Quality Management, Cord Blood, and Cellular Therapy. He has served in various technical and managerial roles in the UK and Canada. He is the Quality Manager for the Cellular Therapy & Transplantation Service at The Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, Ontario, Canada.
Ed has continued to represent Quality in the Clinical Laboratory and Cellular Therapy space and has presented at international scientific conferences and webinars related to Quality Operations, Cord Blood, and Cellular Therapy. He is a member of the FACT HPC Standards and Quality Management Committee, the Canadian Society for Medical Lab Science, and the Canadian Standards Association (CSA). He actively participates in the BMT and Cellular Therapy Laboratory National Standards. Ed continues to advocate for quality and loves to share his passion for continuous quality improvement to enable facilities to meet International Regulatory and Accreditation Standards.
No Disclosures.
-
The 2023 QM Series 12 theme is Embrace Change: Growing Your Cellular Therapy Services. Each webinar will equip your organization with practical strategies and insights to incorporate a new service or product into your cellular therapy organization while ensuring compliance, optimizing patient outcomes, and driving continuous improvement. Each webinar will include a 45-minute live lecture and a 15-minute Q&A session. Jacklyn Stentz, MBA, BSMT(ASCP), CPHQ, is the Director of Quality Improvement for the Sarah Cannon Transplant and Cellular Therapy Network.
After this enduring webinar, participants will be able to:
-
Identify key stakeholders for developing indicators.
-
Define endpoints and develop benchmarks.
-
Recognize improvements while reflecting on expected outcomes.
Purchase the QM Series 12 - Part 1 On-Demand Bundle: PURCHASE
Jacklyn Stentz, MBA, BSMT(ASCP), CPHQ
Director Quality Improvement
Sarah Cannon Transplant and Cellular Therapy Network
Jackie has been in the transplant and cellular therapy field for twenty years. She joined the Sarah Cannon Transplant and Cellular Therapy Network in early 2022, where her primary responsibilities include ensuring compliance with accreditation and regulatory standards through standardizing policies, developing quality tool templates, establishing, and analyzing actionable quality metrics, facilitating mock inspections, and mentoring the quality managers at each of the Network programs. Jackie is a current member of the FACT Quality Management Committee and the FACT-JACIE International Standards for HCT Ninth Edition Quality Management Subcommittee.
No Disclosures.
-
The 2023 QM Series 12 theme is Embrace Change: Growing Your Cellular Therapy Services. Each webinar will equip your organization with practical strategies and insights to incorporate a new service or product into your cellular therapy organization while ensuring compliance, optimizing patient outcomes, and driving continuous improvement. Each webinar includes a 45-minute live lecture and a 15-minute Q&A session. Jay Tann, MS, RAC, is the quality assurance manager of the Children's National Health System Blood and Marrow Transplant Program.
After this enduring webinar, participants will be able to:
-
Describe what a written agreement is and the purpose it serves.
-
Identify when a written agreement is necessary based on FACT Standards.
-
Compare and contrast quality agreements vs. financial/operational agreements.
-
Determine what key elements should be included within written agreements.
Purchase the QM Series 12 - Part 1 On-Demand Bundle: PURCHASE
Jay Tanna
Quality Assurance Manager
Children's National Health System Blood and Marrow Transplant Program
Nothing to Disclose.
-
The 2023 QM Series 12 theme is Embrace Change: Growing Your Cellular Therapy Services. Each webinar will equip your organization with practical strategies and insights to incorporate a new service or product into your cellular therapy organization while ensuring compliance, optimizing patient outcomes, and driving continuous improvement. This webinar includes 45 minutes of live lecture and a 15-minute Q&A session. Presentation #1 by Dr. Juan A. Merayo-Rodriguez, MD, CABP; Presentation #2 by Karen Collum, DNP, RN, OCN; Presentation #3 by Korrynn Vincent BS.
After this enduring webinar, participants will be able to:
-
Presentation #1: Evaluate the requirements for new products or services; execute a change control workshop for new products or services; and demonstrate the management and documentation of change to comply with FACT Standards.
-
Presentation #2: Construct actionable process metrics for clinical quality indicators; analyze outcome metrics for clinical quality indicators; and implement a benchmarking plan for clinical quality indicators.
-
Presentation #3: Review the distinct types of written agreements describing appropriate review and approval processes; explain FACT's requirements for written agreements; and define quality agreements and outline their critical elements.
Purchase the QM Series 12 - Part 1 On-Demand Bundle: Purchase
Juan Merayo-Rodriguez, MD
Cord Blood Bank Director, LifeCord
LifeSouth Cord Blood Bank
No Disclosures.
Karen Collum, DNP, RN, OCN
Director, Nursing Quality
Memorial Sloan-Kettering Cancer Center - Blood and Marrow Transplant Program
Karen Collum is Director of Nursing Quality at Memorial Sloan Kettering Cancer Center. As the Director, Karen oversees a team of Quality Management Nurses and Data Analysts who support the 4000+ nursing staff in monitoring patient outcomes, patient experience, and staff satisfaction through the tracking and reporting (internally and externally) of over 50 metrics. Karen also provides quality oversight to the transplant and cellular therapy programs and manages the organizational FACT accreditation. Karen has been a nurse for 21 years, with 15 years working in quality. Before her role as Director, Karen was the Nurse Leader for Nursing Quality & Transplant Services. Karen is a Felician University graduate with a Doctor of Nursing Practice degree in Nursing Executive Leadership.
TOPIC: Data Collection & Sample Size Justification
No Disclosures.
Korrynn Vincent, BS
Laboratory Manager
Carolinas Cord Blood Bank at Duke
No Disclosures.
-
The 2023 QM Series 12 theme is Embrace Change: Growing Your Cellular Therapy Services. Each webinar will equip your organization with practical strategies and insights to incorporate a new service or product into your cellular therapy organization while ensuring compliance, optimizing patient outcomes, and driving continuous improvement. Each webinar will include a 45-minute live lecture and a 15-minute Q&A session. Ed Brindle, MSc, MLT is the Quality Manager for the Hamilton Health Sciences, Cellular Therapy and Transplantation Program.
After this webinar, attendees should be able to:
-
Determine a timeline, regulatory requirements, and potential metrics to assess needs.
-
Evaluate potential benefits and value added by performing a needs assessment.
-
Identify gaps through change control and how they affect other processes within the program.
-
Assess staffing, training, and product needs for the successful implementation of a new service.
Purchase the QM Series 12 - Part 1 On-Demand Bundle: PURCHASEEd Brindle
QA Manager - CTT Program
Hamilton Health Sciences
Ed's extensive educational background and professional certifications testify to his qualifications. He holds a Bachelor’s in Biological Sciences from Glasgow Caledonian University, a master’s in biomedical sciences at Napier University in Edinburgh, UK, and a Certificate in Quality Management with distinction at the University of Manitoba. Ed's unwavering dedication to quality management is evident in his over 30 years of experience as a Medical Lab Technologist in Hematology, Transfusion, Microbiology, Clinical Biochemistry, Quality Management, Cord Blood, and Cellular Therapy. He has served in various technical and managerial roles in the UK and Canada. He is the Quality Manager for the Cellular Therapy & Transplantation Service at The Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, Ontario, Canada.
Ed has continued to represent Quality in the Clinical Laboratory and Cellular Therapy space and has presented at international scientific conferences and webinars related to Quality Operations, Cord Blood, and Cellular Therapy. He is a member of the FACT HPC Standards and Quality Management Committee, the Canadian Society for Medical Lab Science, and the Canadian Standards Association (CSA). He actively participates in the BMT and Cellular Therapy Laboratory National Standards. Ed continues to advocate for quality and loves to share his passion for continuous quality improvement to enable facilities to meet International Regulatory and Accreditation Standards.
No Disclosures.
-
-
The 2023 QM Series 12 theme is Embrace Change: Growing Your Cellular Therapy Services. Each webinar will equip your organization with practical strategies and insights to incorporate a new service or product into your cellular therapy organization while ensuring compliance, optimizing patient outcomes, and driving continuous improvement. Each webinar will include a 45-minute live lecture and a 15-minute Q&A session. Jacklyn Stentz, MBA, BSMT(ASCP), CPHQ, is the Director of Quality Improvement for the Sarah Cannon Transplant and Cellular Therapy Network.
After this enduring webinar, participants will be able to:
-
Identify key stakeholders for developing indicators.
-
Define endpoints and develop benchmarks.
-
Recognize improvements while reflecting on expected outcomes.
Purchase the QM Series 12 - Part 1 On-Demand Bundle: PURCHASEJacklyn Stentz, MBA, BSMT(ASCP), CPHQ
Director Quality Improvement
Sarah Cannon Transplant and Cellular Therapy Network
Jackie has been in the transplant and cellular therapy field for twenty years. She joined the Sarah Cannon Transplant and Cellular Therapy Network in early 2022, where her primary responsibilities include ensuring compliance with accreditation and regulatory standards through standardizing policies, developing quality tool templates, establishing, and analyzing actionable quality metrics, facilitating mock inspections, and mentoring the quality managers at each of the Network programs. Jackie is a current member of the FACT Quality Management Committee and the FACT-JACIE International Standards for HCT Ninth Edition Quality Management Subcommittee.
No Disclosures.
-
-
The 2023 QM Series 12 theme is Embrace Change: Growing Your Cellular Therapy Services. Each webinar will equip your organization with practical strategies and insights to incorporate a new service or product into your cellular therapy organization while ensuring compliance, optimizing patient outcomes, and driving continuous improvement. Each webinar includes a 45-minute live lecture and a 15-minute Q&A session. Jay Tann, MS, RAC, is the quality assurance manager of the Children's National Health System Blood and Marrow Transplant Program.
After this enduring webinar, participants will be able to:
-
Describe what a written agreement is and the purpose it serves.
-
Identify when a written agreement is necessary based on FACT Standards.
-
Compare and contrast quality agreements vs. financial/operational agreements.
-
Determine what key elements should be included within written agreements.
Purchase the QM Series 12 - Part 1 On-Demand Bundle: PURCHASEJay Tanna
Quality Assurance Manager
Children's National Health System Blood and Marrow Transplant Program
Nothing to Disclose.
-
-
The 2023 QM Series 12 theme is Embrace Change: Growing Your Cellular Therapy Services. Each webinar will equip your organization with practical strategies and insights to incorporate a new service or product into your cellular therapy organization while ensuring compliance, optimizing patient outcomes, and driving continuous improvement. This webinar includes 45 minutes of live lecture and a 15-minute Q&A session. Presentation #1 by Dr. Juan A. Merayo-Rodriguez, MD, CABP; Presentation #2 by Karen Collum, DNP, RN, OCN; Presentation #3 by Korrynn Vincent BS.
After this enduring webinar, participants will be able to:
-
Presentation #1: Evaluate the requirements for new products or services; execute a change control workshop for new products or services; and demonstrate the management and documentation of change to comply with FACT Standards.
-
Presentation #2: Construct actionable process metrics for clinical quality indicators; analyze outcome metrics for clinical quality indicators; and implement a benchmarking plan for clinical quality indicators.
-
Presentation #3: Review the distinct types of written agreements describing appropriate review and approval processes; explain FACT's requirements for written agreements; and define quality agreements and outline their critical elements.
Purchase the QM Series 12 - Part 1 On-Demand Bundle: PurchaseJuan Merayo-Rodriguez, MD
Cord Blood Bank Director, LifeCord
LifeSouth Cord Blood Bank
No Disclosures.
Karen Collum, DNP, RN, OCN
Director, Nursing Quality
Memorial Sloan-Kettering Cancer Center - Blood and Marrow Transplant Program
Karen Collum is Director of Nursing Quality at Memorial Sloan Kettering Cancer Center. As the Director, Karen oversees a team of Quality Management Nurses and Data Analysts who support the 4000+ nursing staff in monitoring patient outcomes, patient experience, and staff satisfaction through the tracking and reporting (internally and externally) of over 50 metrics. Karen also provides quality oversight to the transplant and cellular therapy programs and manages the organizational FACT accreditation. Karen has been a nurse for 21 years, with 15 years working in quality. Before her role as Director, Karen was the Nurse Leader for Nursing Quality & Transplant Services. Karen is a Felician University graduate with a Doctor of Nursing Practice degree in Nursing Executive Leadership.
TOPIC: Data Collection & Sample Size Justification
No Disclosures.
Korrynn Vincent, BS
Laboratory Manager
Carolinas Cord Blood Bank at Duke
No Disclosures.
-
Promoting quality patient care and
laboratory practice in cellular
therapies
Principal
Members:
© 2024 The Foundation for the Accreditation of Cellular Therapy.
All Rights Reserved.